Home

Natco Pharma Ltd PE Ratio

Image

Natco Pharma Ltd

NSE: NATCOPHARM

PE

11.6

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Natco Pharma Ltd is 11.6 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Natco Pharma Ltd changed from 20 on March 2020 to 12.3 on March 2024 . This represents a CAGR of -9.26% over 5 years.
  • The Latest Trading Price of Natco Pharma Ltd is ₹ 1220 as of 15 Jan 15:48 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Natco Pharma Ltd

No data available

Company Fundamentals for Natco Pharma Ltd

Image

Natco Pharma Ltd

NSE: NATCOPHARM

Share Price

₹ 1220.6

-35.20 (-2.80%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251255.8
13 Jan 20251212.35
10 Jan 20251235.5
09 Jan 20251288.95
08 Jan 20251318.7
07 Jan 20251326.6
06 Jan 20251310.15
03 Jan 20251366.85
02 Jan 20251385.35
01 Jan 20251398.7

SWOT Analysis Of Natco Pharma Ltd

Strength

4

che

Weakness

3

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Natco Pharma Ltd

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Natco Pharma Ltd22492
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Natco Pharma Ltd Explained

``

22492

Market cap

1944

Earnings

11.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Natco Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Natco Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Natco Pharma Ltd

No data available

* All values are in %

About Natco Pharma Ltd

  • Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs).
  • The Company's focus is primarily on niche therapeutic areas and complex products.
  • It sells products in over 40 countries.
  • FDF products are sold in the United States, India, Europe and the rest of the world (RoW).
  • Natco's API products are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets such as Brazil, Europe and USA. In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Natco Pharma is also engaged in contract manufacturing business, whereby the company undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products.

Natco Pharma Ltd News Hub

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad

Read more

2024-09-04 00:00:00

Natco Pharma fixes record date for second interim dividend

Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The

Read more

2024-08-12 00:00:00

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2

Read more

2024-08-12 00:00:00

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30

Read more

2024-08-12 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Natco Pharma Ltd

What is the current PE Ratio of Natco Pharma Ltd?

The Current PE Ratio of Natco Pharma Ltd is 11.57 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Natco Pharma Ltd last year?

The PE Ratio of Natco Pharma Ltd was 14.38 last year, now the PE ratio is 11.57, showing a year-on-year growth of -19.5%.

What does the PE Ratio of Natco Pharma Ltd indicate about its stock?

The PE Ratio of Natco Pharma Ltd is 11.57. This ratio indicates that investors are willing to pay 11.57 times the earnings per share for each share of Natco Pharma Ltd.

What is the PE Ratio Growth of Natco Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Natco Pharma Ltd grew by -19.5% whereas, the EPS ratio grew by 1.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions